CONMED Corporation (CNMD) News

CONMED Corporation (CNMD): $112.01

2.16 (+1.97%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter CNMD News Items

CNMD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CNMD News Highlights

  • For CNMD, its 30 day story count is now at 3.
  • Over the past 24 days, the trend for CNMD's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • MSCI and HSIC are the most mentioned tickers in articles about CNMD.

Latest CNMD News From Around the Web

Below are the latest news stories about CONMED Corp that investors may wish to consider to help them evaluate CNMD as an investment opportunity.

Conmed (CNMD) Up 14% Since Last Earnings Report: Can It Continue?

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | February 25, 2022

HSIC or CNMD: Which Is the Better Value Stock Right Now?

HSIC vs. CNMD: Which Stock Is the Better Value Option?

Yahoo | February 9, 2022

Calamos Wealth Management Llc Buys SPDR Bloomberg Convertible Securities ETF, iShares Core ...

Naperville, IL, based Investment company Calamos Wealth Management Llc (Current Portfolio) buys SPDR Bloomberg Convertible Securities ETF, iShares Core S&P Small-Cap ETF, iShares MSCI ACWI Ex US Index Fund, Broadcom Inc, Boeing Co, sells PayPal Holdings Inc, Vonage Holdings Corp, ServiceNow Inc, BTC iShares MSCI EAFE Min Vol Factor ETF, Southwest Airlines Co during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Calamos Wealth Management Llc.

Yahoo | February 1, 2022

Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...

Yahoo | January 28, 2022

Conmed Posts Mixed Bag Q4 Earnings, Issues FY22 Outlook

CONMED Corporation (NYSE: CNMD ) reported Q4 FY21 adjusted EPS of $1.07 , compared to $0.84 a year ago, and better than the consensus of $1.06. Sales for the quarter rose 8.4% Y/Y to $273.97 million, missing the consensus of $278.76 … Full story available on Benzinga.com

Benzinga | January 27, 2022

CONMED's (CNMD) Q4 Earnings Beat Estimates, Revenues Miss

CONMED's (CNMD) fourth-quarter earnings reflect strong segmental performance.

Yahoo | January 27, 2022

CONMED Corporation (CNMD) CEO Curt Hartman on Q4 2021 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | January 26, 2022

Conmed (CNMD) Tops Q4 Earnings Estimates

Conmed (CNMD) delivered earnings and revenue surprises of 1.90% and 1.25%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | January 26, 2022

CONMED Corporation Announces Fourth Quarter and Full-Year 2021 Financial Results

LARGO, Fla., January 26, 2022--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2021.

Yahoo | January 26, 2022

Conmed (CNMD) Reports Next Week: Wall Street Expects Earnings Growth

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | January 19, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5261 seconds.